Judge Orders Arbitration in Anthem Coverage Lawsuit
An L.A. judge sent a weight loss drug coverage dispute to arbitration, pausing the civil case against Anthem Blue Cross.
Updated on Oct. 20, 2026 in Weight Loss
Live Poll
Should insurance companies continue covering weight-loss medication after a patient reaches a healthy weight?
Judge Colin Leis has ordered Alicia Butterfield to pursue arbitration in her lawsuit against Anthem Blue Cross over a denied coverage request for the weight loss medication Zepbound. The Los Angeles Superior Court has stayed the civil proceedings pending the resolution of the arbitration process.
Why it matters
The ruling clarifies that state arbitration disclosure requirements do not apply to Covered California insurance plans, potentially impacting how other policyholders resolve coverage disputes. Anthem maintains that its denial was based on plan criteria requiring a diagnosis of diabetes or morbid obesity.
In 2022, the plaintiff successfully obtained coverage for Mounjaro based on a body-mass index threshold of 40. The current dispute involves an April 2025 denial of Zepbound after the patient fell below the morbid obesity threshold.
The players
Alicia Butterfield
She is the plaintiff in the lawsuit who is seeking coverage for her weight loss medication.
Anthem Blue Cross
This is the health insurance provider that denied coverage for the medication Zepbound.
Colin Leis
He is the Los Angeles Superior Court judge who issued the ruling ordering the case to arbitration.
The details
Alicia Butterfield alleged breach of contract after Anthem rejected her Zepbound claim, arguing that her successful weight loss rendered her ineligible under the insurer's criteria. Anthem had previously approved coverage for a different medication, Mounjaro, for the plaintiff in 2022 before she switched to her current Anthem HMO plan in early 2025.
Timeline
In 2022, Blue Shield approved coverage for the drug Mounjaro.
The plaintiff switched to an Anthem HMO plan in February 2025.
Anthem officially denied the request for Zepbound in April 2025.
Alicia Butterfield filed the lawsuit in July 2025.
A status conference is scheduled for April 19, 2027.
Health Landscape
This decision marks a significant legal interpretation of the California Health and Safety Code arbitration disclosure requirements. By excluding Covered California plans from these specific mandates, the court sets a trajectory that may limit the legal avenues available to policyholders in similar coverage disputes.
For patients covered under similar plans, this ruling underscores the importance of reviewing the arbitration clauses found in their insurance contracts. It signifies that disputes over coverage criteria may be diverted away from jury trials, potentially changing how individuals contest insurer-denied medications.
The takeaway
Patients should carefully review the specific terms of their insurance plans regarding arbitration to understand their rights in coverage disputes. Staying informed about how personal medical history impacts eligibility criteria can help in navigating potential denials for weight loss treatments.
What happens next
A status conference for the legal case is scheduled to take place on April 19, 2027.
Further reading
Find more updates on Weight Loss issues in the Los Angeles area.
Source note: This article includes information reported by My News LA.
Live Poll
Should insurance companies continue covering weight-loss medication after a patient reaches a healthy weight?
